CLEARONE INC (CLRO)

US18506U1043 - Common Stock

0.49  -0.01 (-1.01%)

After market: 0.6279 +0.14 (+28.14%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CLRO. CLRO was compared to 51 industry peers in the Communications Equipment industry. While CLRO has a great health rating, there are worries on its profitability. CLRO is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year CLRO has reported negative net income.
CLRO had a negative operating cash flow in the past year.
In multiple years CLRO reported negative net income over the last 5 years.
In the past 5 years CLRO reported 4 times negative operating cash flow.

1.2 Ratios

CLRO has a Return On Assets of -11.12%. This is in the lower half of the industry: CLRO underperforms 64.71% of its industry peers.
The Return On Equity of CLRO (-13.41%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -11.12%
ROE -13.41%
ROIC N/A
ROA(3y)3.94%
ROA(5y)-0.52%
ROE(3y)3.85%
ROE(5y)-1.27%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CLRO's Gross Margin of 28.92% is on the low side compared to the rest of the industry. CLRO is outperformed by 72.55% of its industry peers.
In the last couple of years the Gross Margin of CLRO has declined.
CLRO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.69%
GM growth 5Y-6.47%

7

2. Health

2.1 Basic Checks

CLRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLRO has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLRO has more shares outstanding
There is no outstanding debt for CLRO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of 1.54, we must say that CLRO is in the distress zone and has some risk of bankruptcy.
CLRO has a Altman-Z score (1.54) which is in line with its industry peers.
There is no outstanding debt for CLRO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.54
ROIC/WACCN/A
WACC10.79%

2.3 Liquidity

A Current Ratio of 6.95 indicates that CLRO has no problem at all paying its short term obligations.
CLRO has a better Current ratio (6.95) than 94.12% of its industry peers.
CLRO has a Quick Ratio of 2.95. This indicates that CLRO is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CLRO (2.95) is better than 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 6.95
Quick Ratio 2.95

0

3. Growth

3.1 Past

The earnings per share for CLRO have decreased strongly by -120.65% in the last year.
The Revenue for CLRO has decreased by -24.92% in the past year. This is quite bad
The Revenue has been decreasing by -7.86% on average over the past years.
EPS 1Y (TTM)-120.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-194.12%
Revenue 1Y (TTM)-24.92%
Revenue growth 3Y-13.67%
Revenue growth 5Y-7.86%
Sales Q2Q%-57.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

CLRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

CLRO has a Yearly Dividend Yield of 101.01%, which is a nice return.
CLRO's Dividend Yield is rather good when compared to the industry average which is at 11.72. CLRO pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.19, CLRO pays a better dividend.
Industry RankSector Rank
Dividend Yield 101.01%

5.2 History

On average, the dividend of CLRO grows each year by 50.73%, which is quite nice.
CLRO has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)50.73%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CLRO has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-422.91%
EPS Next 2YN/A
EPS Next 3YN/A

CLEARONE INC

NASDAQ:CLRO (11/25/2024, 8:00:00 PM)

After market: 0.6279 +0.14 (+28.14%)

0.49

-0.01 (-1.01%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap11.75M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 101.01%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.12%
ROE -13.41%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 28.92%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 6.95
Quick Ratio 2.95
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-120.65%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-24.92%
Revenue growth 3Y-13.67%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y